IGM Biosciences, Inc. Operating Lease Liability
IGM Biosciences, Inc. had Operating Lease Liability of $43.20 million as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-07-31
- 2025-06-30: Operating Lease, Liability $43.20M.
- 2024-12-31: Operating Lease, Liability $45.19M.
- 2023-12-31: Operating Lease, Liability $40.51M.
- 2022-12-31: Operating Lease, Liability $41.17M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-06-30 | $43.20M 10-Q · filed 2025-07-31 |
| 2024-12-31 | $45.19M 10-K · filed 2025-03-06 |
| 2023-12-31 | $40.51M 10-K · filed 2024-03-07 |
| 2022-12-31 | $41.17M 10-K · filed 2023-03-30 |
| 2021-12-31 | $28.76M 10-K · filed 2022-03-29 |
| 2021-09-30 | $29.38M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $12.64M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $13.38M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $12.24M 10-K · filed 2021-03-30 |
| 2020-09-30 | $12.88M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $13.51M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $14.12M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $14.73M 10-K · filed 2020-03-26 |
| 2019-09-30 | $10.37M 10-Q · filed 2019-11-07 |
| 2019-01-01 | $700.00K 10-Q · filed 2019-11-07 |